{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:10:01Z","timestamp":1750536601990,"version":"3.41.0"},"reference-count":110,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2000,4,1]],"date-time":"2000-04-01T00:00:00Z","timestamp":954547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advances in Renal Replacement Therapy"],"published-print":{"date-parts":[[2000,4]]},"DOI":"10.1053\/rr.2000.5272","type":"journal-article","created":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T16:42:44Z","timestamp":1499704964000},"page":"158-171","source":"Crossref","is-referenced-by-count":11,"title":["Progress in Renal Transplantation for Children"],"prefix":"10.1053","volume":"7","author":[{"given":"Jodi M.","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth A.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/rr.2000.5272_bib1","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0031-3955(16)36268-X","article-title":"The therapeutic approach to the infant, child and adolescent with end stage renal disease","volume":"34","author":"Fine","year":"1987","journal-title":"Pediatr Clin North Am"},{"key":"10.1053\/rr.2000.5272_bib2","series-title":"Renal Disease in Children","first-page":"371","article-title":"Renal transplantation","author":"Ettenger","year":"1990"},{"key":"10.1053\/rr.2000.5272_bib3","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/00007890-199402270-00013","article-title":"Posttransplant deaths and factors that influence the mortality rate in North American Children","volume":"57","author":"Tejani","year":"1994","journal-title":"Transplantation"},{"key":"10.1053\/rr.2000.5272_bib4","first-page":"360A","article-title":"Increased mortality among peritoneal dialysis (PD) 0\u20135 years of age compared to older pediatric PD and hemodialysis (HD) patients. A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Abstract","volume":"35","author":"Alexander","year":"1994","journal-title":"Pediatr Res"},{"key":"10.1053\/rr.2000.5272_bib5","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00000658-199809000-00015","article-title":"Kidney transplantation in children younger than 1 year using cyclosporine immunosuppression","volume":"228","author":"Humar","year":"1998","journal-title":"Ann Surg"},{"key":"10.1053\/rr.2000.5272_bib6","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/00007890-199702270-00013","article-title":"Renal transplantation in children less than two years old","volume":"63","author":"Tyden","year":"1997","journal-title":"Transplantation"},{"key":"10.1053\/rr.2000.5272_bib7","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/BF00869842","article-title":"The 1989 report of the North American Pediatric Renal Transplant Cooperative Study","volume":"4","author":"Alexander","year":"1990","journal-title":"Pediatr Nephrol"},{"year":"1989","series-title":"USRDS 1989 Annual Data Report","key":"10.1053\/rr.2000.5272_bib8"},{"key":"10.1053\/rr.2000.5272_bib9","unstructured":"UNOS Policy and By-laws. Policy 3.5.9.5: Pediatric kidney transplant candidates. Effective March 10, 1997"},{"key":"10.1053\/rr.2000.5272_bib10","unstructured":"UNOS Policy and By-laws Appendix. Policy 3.5.9.5.2: Pediatric goals for transplanting kidney transplant candidates. Effective November 23, 1998"},{"key":"10.1053\/rr.2000.5272_bib11","unstructured":"UNOS Policy and By-laws Appendix. Policy 3.5.9.5.1: Pediatric kidney transplant candidates not transplanted within time goals policy. Effective November 23,1998"},{"key":"10.1053\/rr.2000.5272_bib12","first-page":"263","article-title":"Recommended immunization practices for pediatric renal transplant recipients","volume":"2","author":"Neu","year":"1998","journal-title":"Pediatr Transplant"},{"key":"10.1053\/rr.2000.5272_bib13","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1542\/peds.101.1.154","article-title":"Recommended childhood immunization schedule\u2014United States, January\u2013December 1998","volume":"101","year":"1998","journal-title":"Pediatrics"},{"key":"10.1053\/rr.2000.5272_bib14","first-page":"256","article-title":"Immunization guidelines for pediatric renal disease","volume":"18","author":"Fivush","year":"1998","journal-title":"Semin Nephrol"},{"key":"10.1053\/rr.2000.5272_bib15","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/BF00865476","article-title":"Attenuated varicella virus vaccine in children with renal transplants","volume":"8","author":"Zamora","year":"1994","journal-title":"Pediatr Nephrol"},{"key":"10.1053\/rr.2000.5272_bib16","first-page":"253","article-title":"Effect of blood transfusion on subsequent kidney transplants","volume":"4","author":"Opelz","year":"1973","journal-title":"Transplant Proc"},{"key":"10.1053\/rr.2000.5272_bib17","first-page":"431","article-title":"The enigma of blood transfusions and kidney transplantation","volume":"57","author":"Moore","year":"1982","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/rr.2000.5272_bib18","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1542\/peds.76.3.402","article-title":"Deliberate donor-specific transfusions on renal transplantation in children","volume":"76","author":"Salvatierra","year":"1985","journal-title":"Pediatrics"},{"key":"10.1053\/rr.2000.5272_bib19","first-page":"1361","article-title":"Increased antibody responsiveness to blood transfusions in pediatric patients","volume":"58","author":"Scornik","year":"1994","journal-title":"Transplantation"},{"key":"10.1053\/rr.2000.5272_bib20","first-page":"22","article-title":"Pretransplant blood transfusion and renal allograft outcome: A report of the North American Pediatric Renal Transplant Cooperative Study","volume":"1","author":"Chavers","year":"1997","journal-title":"Pediatr Transplant"},{"key":"10.1053\/rr.2000.5272_bib21","first-page":"2","article-title":"Urologic evaluation in renal transplantation","volume":"12","author":"Gonzalez","year":"1989","journal-title":"Dialogues in pediatric urology"},{"key":"10.1053\/rr.2000.5272_bib22","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/0022-3468(92)90306-R","article-title":"Treatment of bladder dysfunction in children with end-stage-renal disease","volume":"27","author":"Burns","year":"1992","journal-title":"J Pediatr Surg"},{"key":"10.1053\/rr.2000.5272_bib23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1034\/j.1399-3046.2000.00078.x","article-title":"Asymptomatic inferior vena cava abnormalities in three children with end stage renal disease: Risk factors and screening guidelines for pretransplant diagnosis","volume":"4","author":"Thomas","year":"2000","journal-title":"Pediatr Transplant"},{"key":"10.1053\/rr.2000.5272_bib24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1034\/j.1399-3046.1999.00001.x","article-title":"Trends in immunosuppressive therapy","volume":"3","author":"Benfield","year":"1999","journal-title":"Pediatr Transplant"},{"key":"10.1053\/rr.2000.5272_bib25","first-page":"819","article-title":"Transplantation immunology","volume":"41","author":"Krensky","year":"1994","journal-title":"Clin Immunol"},{"key":"10.1053\/rr.2000.5272_bib26","first-page":"2259","article-title":"Conversion from Sandimmune to Neoral and induction therapy with Neoral in pediatric renal transplant recipients","volume":"28","author":"Hoyer","year":"1996","journal-title":"Transplant Proc"},{"key":"10.1053\/rr.2000.5272_bib27","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1399-0012.1996.tb00733.x","article-title":"The importance of early cyclosporine levels in pediatric kidney transplantation","volume":"10","author":"Matas","year":"1996","journal-title":"Clin Transplant"},{"key":"10.1053\/rr.2000.5272_bib28","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1681\/ASN.V74550","article-title":"Higher maintenance cyclosporine dose decreases the risk of graft failure in North American children: A report of the North American Pediatric Renal Transplant Cooperative Study","volume":"7","author":"Tejani","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/rr.2000.5272_bib29","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1399-0012.1998.tb01008.x","article-title":"Development of Sang-35: A cyclosporine formulation bioequivalent to Neoral","volume":"12","author":"First","year":"1998","journal-title":"Clin Transplant"},{"key":"10.1053\/rr.2000.5272_bib30","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0041-1345(96)00480-0","article-title":"A generic cyclosporine development program","volume":"29","author":"Schroeder","year":"1997","journal-title":"Trans Proc"},{"key":"10.1053\/rr.2000.5272_bib31","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/S0022-5347(17)37635-8","article-title":"Pediatric renal transplantation under FK-506 immunosuppression","volume":"147","author":"Schenck","year":"1991","journal-title":"J Urol"},{"key":"10.1053\/rr.2000.5272_bib32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF00865477","article-title":"Comparison of FK-506 and cyclosporine regimens in pediatric renal transplantation","volume":"8","author":"Ellis","year":"1994","journal-title":"Pediatr Nephrol"},{"key":"10.1053\/rr.2000.5272_bib33","first-page":"270","article-title":"Tacrolimus in pediatric renal transplantation: A review","volume":"2","author":"Shapiro","year":"1998","journal-title":"Pediatr Transplantation"},{"key":"10.1053\/rr.2000.5272_bib34","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1007\/BF00867683","article-title":"FK 506 in pediatric kidney transplantation\u2014Primary and rescue experience","volume":"9","author":"Shapiro","year":"1995","journal-title":"Pediatr Nephrol"},{"key":"10.1053\/rr.2000.5272_bib35","first-page":"993","article-title":"Preliminary experience with FK 506 in pediatric renal transplant recipients: A single center report","volume":"28","author":"Birk","year":"1996","journal-title":"Transplant Proc"},{"key":"10.1053\/rr.2000.5272_bib36","first-page":"3144","article-title":"RS-61443: A new immunosuppressive agent","volume":"26","author":"Young","year":"1994","journal-title":"Transplant Proc"},{"key":"10.1053\/rr.2000.5272_bib37","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(95)92534-1","article-title":"Placebo controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection","volume":"345","year":"1995","journal-title":"Lancet"},{"key":"10.1053\/rr.2000.5272_bib38","first-page":"225","article-title":"US Renal Transplant Mycophenolate Mofetil Study Group","volume":"60","author":"Sollinger","year":"1995","journal-title":"Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation"},{"key":"10.1053\/rr.2000.5272_bib39","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00007890-199604150-00008","article-title":"A blinded, randomized, clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation","volume":"61","year":"1996","journal-title":"Transplantation"},{"key":"10.1053\/rr.2000.5272_bib40","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1034\/j.1399-3046.1999.00003.x","article-title":"Mycophenolate mofetil in pediatric renal transplantation","volume":"3","author":"Benfield","year":"1999","journal-title":"Pediatr Transplant"},{"key":"10.1053\/rr.2000.5272_bib41","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1097\/00007890-199904150-00499","article-title":"The long-term use of mycophenolate mofetil in pediatric renal transplantation. A report of the pediatric MMF study group","volume":"67","author":"Ettenger","year":"1999","journal-title":"Transplantation"},{"key":"10.1053\/rr.2000.5272_bib42","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1034\/j.1399-3046.1999.00015.x","article-title":"Mycophenolate mofetil\u2014Is it worth the cost? The in-favor opinion","volume":"3","author":"Seikaly","year":"1999","journal-title":"Pediatr Transplant"},{"key":"10.1053\/rr.2000.5272_bib43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1034\/j.1399-3046.1999.00016.x","article-title":"What is the role for mycophenolate mofetil in pediatric renal transplantation?","volume":"3","author":"Neu","year":"1999","journal-title":"Pediatr Transplant"},{"key":"10.1053\/rr.2000.5272_bib44","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1084\/jem.176.3.751","article-title":"The immunosuppressive and toxic effects of FK 506 are mechanistically related: Pharmacology of a novel antagonism of FK 506 and rapamycin","volume":"176","author":"Dumont","year":"1992","journal-title":"J Exp Med"},{"key":"10.1053\/rr.2000.5272_bib45","article-title":"Effect of rapamycin, cyclosporin A, and prednisolone on murine thymocyte proliferation in vitro","author":"Baeder","year":"1989","journal-title":"Wyeth-Ayerst Research GTR-18812"},{"key":"10.1053\/rr.2000.5272_bib46","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/S0041-1345(98)00585-5","article-title":"Rapamycin: Personal algorithms for use based on 250 treated renal allograft recipients","volume":"30","author":"Kahan","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1053\/rr.2000.5272_bib47","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/00007890-199904150-00017","article-title":"Sirolimus-based therapy in human renal transplantation: Similar efficacy and different toxicity compared with cyclosporine","volume":"67","year":"1999","journal-title":"Transplantation"},{"key":"10.1053\/rr.2000.5272_bib48","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1034\/j.1399-3046.1999.00036.x","article-title":"The potential role of rapamycin in pediatric transplantation as observed from adult studies","volume":"3","author":"Kahan","year":"1999","journal-title":"Pediatr Transplant"},{"key":"10.1053\/rr.2000.5272_bib49","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1097\/00007890-199805150-00023","article-title":"Hyperlipidemia in renal transplant recipients treated with sirolimus-(rapamycin)","volume":"65","author":"Brattstrom","year":"1998","journal-title":"Transplantation"},{"key":"10.1053\/rr.2000.5272_bib50","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00007890-199707150-00008","article-title":"SDZ RAD, a new rapamycin derivative: Pharmacological properties in vitro and in vivo","volume":"64","author":"Schuler","year":"1997","journal-title":"Transplantation"},{"key":"10.1053\/rr.2000.5272_bib51","first-page":"462","article-title":"The clinical value of antilymphocyte antibodies","volume":"13","author":"Cosimi","year":"1981","journal-title":"Transplant Proc"},{"key":"10.1053\/rr.2000.5272_bib52","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00007890-198802000-00021","article-title":"Reexposure to OKT3 in renal allograft recipients","volume":"45","author":"Mayes","year":"1988","journal-title":"Transplantation"},{"key":"10.1053\/rr.2000.5272_bib53","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1016\/S0041-1345(99)00527-8","article-title":"Antibody therapy as an induction regimen in pediatric renal transplantation","volume":"31","author":"Ettenger","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1053\/rr.2000.5272_bib54","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/00007890-199904150-00013","article-title":"A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients","volume":"67","author":"Brennan","year":"1999","journal-title":"Transplantation"},{"issue":"3B Suppl","key":"10.1053\/rr.2000.5272_bib55","doi-asserted-by":"crossref","first-page":"16S","DOI":"10.1016\/S0041-1345(99)00096-2","article-title":"Leukocyte response to Thymoglobulin or Atgam for induction immunosuppression in a randomized, double-blind clinical trial in renal transplant recipients","volume":"31","author":"Brennan","year":"1999","journal-title":"Transplant Proc"},{"issue":"Suppl 7A","key":"10.1053\/rr.2000.5272_bib56","doi-asserted-by":"crossref","first-page":"6S","DOI":"10.1016\/S0041-1345(97)80454-X","article-title":"Lymphocyte subsets during and after rabbit anti-thymocyte globulin induction in pediatric renal transplantation: Sustained T cell depletion","volume":"29","author":"Bell","year":"1997","journal-title":"Transplant Proc"},{"key":"10.1053\/rr.2000.5272_bib57","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00007890-199901150-00019","article-title":"Reduction of acute renal allograft rejection by daclizumab. Daclizumab double therapy study group","volume":"67","author":"Nashan","year":"1999","journal-title":"Transplantation"},{"key":"10.1053\/rr.2000.5272_bib58","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1056\/NEJM199801153380304","article-title":"Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation","volume":"338","author":"Vincenti","year":"1998","journal-title":"N Engl J Med"},{"journal-title":"Am Soc Transplant Phys Ann Mtg","year":"1998","author":"Ettenger","key":"10.1053\/rr.2000.5272_bib59"},{"key":"10.1053\/rr.2000.5272_bib60","first-page":"276","article-title":"Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody","volume":"67","author":"Kahan","year":"1999","journal-title":"United States Simulect Renal Study Group. Transplantation"},{"key":"10.1053\/rr.2000.5272_bib61","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/S0041-1345(98)02094-6","article-title":"Simulect (basiliximab) reduces acute cellular rejection in renal allografts from cadaveric and living donors","volume":"31","author":"Mulloy","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1053\/rr.2000.5272_bib62","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1097\/00007890-199806150-00022","article-title":"Increased CD 40 ligand gene expression during human renal and murine islet allograft rejection","volume":"65","author":"Zheng","year":"1998","journal-title":"Transplantation"},{"key":"10.1053\/rr.2000.5272_bib63","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ki.1993.234","article-title":"Infectious disease complications of renal transplantation","volume":"44","author":"Rubin","year":"1993","journal-title":"Kidney Int"},{"key":"10.1053\/rr.2000.5272_bib64","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s004670050361","article-title":"Cytomegalovirus infections following renal transplantation-effects on antiviral prophylaxis: A report of the North American Pediatric Renal Transplant Cooperative Study Group","volume":"11","author":"Bock","year":"1997","journal-title":"Pediatr Nephrol"},{"key":"10.1053\/rr.2000.5272_bib65","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/00007890-199201000-00013","article-title":"Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3","volume":"53","author":"Hibberd","year":"1992","journal-title":"Transplantation"},{"key":"10.1053\/rr.2000.5272_bib66","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7326\/0003-4819-123-1-199507010-00002","article-title":"Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients","volume":"123","author":"Hibberd","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1053\/rr.2000.5272_bib67","first-page":"18","article-title":"Cytomegalovirus infection in pediatric kidney transplantation","volume":"26","author":"Fontana","year":"1994","journal-title":"Transplant Proc"},{"key":"10.1053\/rr.2000.5272_bib68","first-page":"20","article-title":"Cytomegalovirus prophylaxis strategies in high-risk transplantation","volume":"26","author":"Snydman","year":"1994","journal-title":"Transplant Proc"},{"key":"10.1053\/rr.2000.5272_bib69","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1399-0012.1997.tb01057.x","article-title":"Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients","volume":"11","author":"Ahsan","year":"1997","journal-title":"Clin Transplant"},{"key":"10.1053\/rr.2000.5272_bib70","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1097\/00007890-199812270-00019","article-title":"A randomized prospective controlled trial of oral acyclovir versus oral ganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipients","volume":"66","author":"Flechner","year":"1998","journal-title":"Transplantation"},{"key":"10.1053\/rr.2000.5272_bib71","first-page":"5","article-title":"Monitoring for cytomegalovirus after organ transplantation: A clinical perspective","volume":"25","author":"The","year":"1993","journal-title":"Transplant Proc"},{"key":"10.1053\/rr.2000.5272_bib72","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0041-1345(98)01985-X","article-title":"Monitoring of CMV infection after renal transplantation: Serology, culture, and viral DNA detection by hybrid capture","volume":"31","author":"Flechner","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1053\/rr.2000.5272_bib73","first-page":"37","article-title":"Varicella in the first year after renal transplantation: A report of the North American Pediatric Renal Transplant Cooperative Study","volume":"1","author":"Furth","year":"1997","journal-title":"Pediatr Transplant"},{"key":"10.1053\/rr.2000.5272_bib74","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0022-3476(81)80527-6","article-title":"Varicella in children with renal transplants","volume":"98","author":"Feldoff","year":"1981","journal-title":"J Pediatr"},{"key":"10.1053\/rr.2000.5272_bib75","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1542\/peds.90.2.216","article-title":"Varicella in pediatric renal transplant recipients","volume":"90","author":"Lynfield","year":"1992","journal-title":"Pediatrics"},{"key":"10.1053\/rr.2000.5272_bib76","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1542\/peds.99.1.35","article-title":"Varicella and zoster in children after kidney transplantation: Long term results of vaccination","volume":"99","author":"Broyer","year":"1997","journal-title":"Pediatrics"},{"key":"10.1053\/rr.2000.5272_bib77","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S0022-3476(97)70036-2","article-title":"Outcome of chickenpox in 66 pediatric renal transplant recipients","volume":"131","author":"Kashtan","year":"1997","journal-title":"J Pediatr"},{"key":"10.1053\/rr.2000.5272_bib78","first-page":"5","article-title":"Epstein-Barr virus-associated lymphoproliferative disorders","volume":"67","author":"Purtilo","year":"1992","journal-title":"Lab Invest"},{"key":"10.1053\/rr.2000.5272_bib79","first-page":"88","article-title":"Posttransplant lymphoproliferative disorder in renal allograft recipients","volume":"56","author":"Cockfield","year":"1993","journal-title":"Clinical experience and risk factor analysis in a single center. Transplantation"},{"key":"10.1053\/rr.2000.5272_bib80","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1681\/ASN.V2121734","article-title":"Epstein-Barr virus infection-associated renal disease: Diagnostic use of molecular hybridization technology in patients with negative serology","volume":"2","author":"Nadasdy","year":"1992","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/rr.2000.5272_bib81","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1399-0012.1995.tb00297.x","article-title":"Antiviral prophylaxis and the Epstein Barr virus related post transplant lymphoproliferative disorder","volume":"9","author":"Davis","year":"1995","journal-title":"Clin Transplant"},{"key":"10.1053\/rr.2000.5272_bib82","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJM199105233242102","article-title":"Anti-B-Cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation","volume":"324","author":"Fischer","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1053\/rr.2000.5272_bib83","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1600-0609.1999.tb01725.x","article-title":"IDEC-C2B8 anti-CD (rituximab) immunotherapy in patients with low-grade non-Hodgkin's lymphoma and lymphoproliferative disorders: Evaluation of response on 48 patients","volume":"62","author":"Nguyen","year":"1999","journal-title":"Eur J Hematol"},{"key":"10.1053\/rr.2000.5272_bib84","first-page":"1334","article-title":"Treatment of B-cell lymphoproliferative disorders with interferon alpha and intravenous gamma globulin","volume":"330","author":"Shapiro","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1053\/rr.2000.5272_bib85","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJM199404283301703","article-title":"Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation","volume":"330","author":"Papadopoulos","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1053\/rr.2000.5272_bib86","doi-asserted-by":"crossref","first-page":"10391","DOI":"10.1073\/pnas.96.18.10391","article-title":"Activation and adoptive transfer of Epstein Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease","volume":"96","author":"Khanna","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/rr.2000.5272_bib87","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1097\/00007890-199705150-00002","article-title":"Autologous lymphokine-activated killer cell therapy of Epstein-Barr virus-positive and negative lymphoproliferative disorders arising in organ transplant recipients","volume":"63","author":"Nalesnik","year":"1997","journal-title":"Transplantation"},{"key":"10.1053\/rr.2000.5272_bib88","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0272-6386(98)70138-6","article-title":"Effective treatment of high-grade lymphoproliferative disorder after renal transplantation using autologous lymphocyte activated killer cell therapy","volume":"32","author":"Li","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/rr.2000.5272_bib89","doi-asserted-by":"crossref","first-page":"S290","DOI":"10.1681\/ASN.V212s290","article-title":"Lymphoproliferative disorders after renal transplantation in patients receiving triple or quadruple immunosuppression","volume":"2","author":"Melosky","year":"1992","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/rr.2000.5272_bib90","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0272-6386(88)80001-5","article-title":"Recurrence of primary renal disease following transplantation","volume":"12","author":"Mathew","year":"1988","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/rr.2000.5272_bib91","series-title":"Kidney Transplantation Principles and Practice","first-page":"635","article-title":"Renal transplantation in children","author":"Fine","year":"1988"},{"key":"10.1053\/rr.2000.5272_bib92","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF00858431","article-title":"Recurrence of focal segmental glomerulosclerosis in transplanted kidneys: Analysis of incidence and risk factors in 59 allografts","volume":"4","author":"Seuggutuvan","year":"1990","journal-title":"Pediatr Nephrol"},{"key":"10.1053\/rr.2000.5272_bib93","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00007890-199001000-00050","article-title":"High-dose cyclosporine therapy in recurrent nephrotic syndrome following renal transplantation","volume":"49","author":"Ingulli","year":"1990","journal-title":"Transplantation"},{"key":"10.1053\/rr.2000.5272_bib94","first-page":"551","article-title":"Recurrence of hemolytic uremic syndrome in renal transplant recipients","volume":"30","author":"Herbert","year":"1986","journal-title":"Kidney Int"},{"key":"10.1053\/rr.2000.5272_bib95","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1093\/ndt\/12.7.1425","article-title":"Recurrence of haemolytic-uraemic syndrome in renal transplants: A single centre report","volume":"12","author":"Miller","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/rr.2000.5272_bib96","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/ki.1991.224","article-title":"Primary hyperoxaluria: Therapeutic strategies for the 90's","volume":"40","author":"Scheinman","year":"1991","journal-title":"Kidney Int"},{"key":"10.1053\/rr.2000.5272_bib97","first-page":"1","article-title":"Treatment of renal failure in the primary hyperoxalurias","volume":"56","author":"Watts","year":"1990","journal-title":"Nephrol"},{"key":"10.1053\/rr.2000.5272_bib98","first-page":"5","article-title":"Controversies in pediatric renal transplantation","volume":"7","author":"Alexander","year":"1990","journal-title":"AKF Nephrology Letter"},{"key":"10.1053\/rr.2000.5272_bib99","series-title":"Advances in Nephrology","first-page":"307","author":"Hamberger","year":"1987"},{"key":"10.1053\/rr.2000.5272_bib100","first-page":"1727","article-title":"Renal transplantation in children","volume":"326","author":"McEnery","year":"1992","journal-title":"A report of the North American Pediatric Renal Transplant Cooperative Study. N Engl J Med"},{"key":"10.1053\/rr.2000.5272_bib101","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00007890-199601150-00008","article-title":"Alternate day steroid dosing improves growth without adversely affecting graft survival or long-term graft function","volume":"61","author":"Jabs","year":"1996","journal-title":"Transplantation"},{"key":"10.1053\/rr.2000.5272_bib102","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/S0022-3476(97)70005-2","article-title":"Growth hormone treatment of renal transplant recipients: The National Cooperative Growth Study experience\u2014A report of the National Cooperative Growth Study and the North American Pediatric Renal Transplant Cooperative Study","volume":"131","author":"Mentser","year":"1997","journal-title":"J Pediatr"},{"key":"10.1053\/rr.2000.5272_bib103","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/00007890-199604150-00011","article-title":"Clinical correlates of chronic rejection in pediatric renal transplantation: A report of the North American Pediatric Renal Transplant Study Group","volume":"7","author":"Tejani","year":"1996","journal-title":"Transplantation"},{"key":"10.1053\/rr.2000.5272_bib104","unstructured":"McDonald R, Donaldson L, Emmett L, et al: A decade of living donor transplantation in North American children: The 1998 annual report of the North American Pediatric Renal Transplant Cooperative Study (in press)"},{"key":"10.1053\/rr.2000.5272_bib105","unstructured":"The 1999 annual report of the North American Pediatric Renal Transplant Cooperative Study (in press)"},{"key":"10.1053\/rr.2000.5272_bib106","unstructured":"Elshihabi I, Chavers B, Donaldson L, et al: Continuing improvement in cadaver donor graft survival in North American children: The 1998 Annual Report of the North American Pediatric Renal Transplant Cooperative Study Group (in press)"},{"issue":"Suppl 4A","key":"10.1053\/rr.2000.5272_bib107","doi-asserted-by":"crossref","first-page":"61S","DOI":"10.1016\/S0041-1345(99)00131-1","article-title":"Pediatric renal transplantation: Back to school issues","volume":"31","author":"Davis","year":"1999","journal-title":"Transplant Proc"},{"issue":"suppl 1","key":"10.1053\/rr.2000.5272_bib108","first-page":"80","article-title":"Quality of life of children post transplantation compared to children on dialysis","volume":"2","author":"Brouhard","year":"1998","journal-title":"Pediatr Transplant"},{"key":"10.1053\/rr.2000.5272_bib109","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF00858429","article-title":"A longitudinal study of the cognitive function of children with renal failure","volume":"4","author":"Fennell","year":"1990","journal-title":"Pediatr Nephrol"},{"key":"10.1053\/rr.2000.5272_bib110","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/BF00866349","article-title":"Cognitive functioning and school performance in children with renal failure","volume":"8","author":"Lawry","year":"1994","journal-title":"Pediatr Nephrol"}],"container-title":["Advances in Renal Replacement Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1073444900700264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1073444900700264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:51:56Z","timestamp":1750535516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1073444900700264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4]]},"references-count":110,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,4]]}},"alternative-id":["S1073444900700264"],"URL":"https:\/\/doi.org\/10.1053\/rr.2000.5272","relation":{},"ISSN":["1073-4449"],"issn-type":[{"type":"print","value":"1073-4449"}],"subject":[],"published":{"date-parts":[[2000,4]]}}}